No profile data available.
Artiva Biotherapeutics, Inc. (ARTV) is a healthcare company in the additional cancer treatment drugs industry, based in San Diego, United States, with about 115 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$83.87 million. Its market capitalization was $339.30 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
Artiva Biotherapeutics reported $0 in revenue for fiscal year 2025, down 100.0% from $251,000 in fiscal year 2024.
$339.30 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Editas Medicine, Inc. (EDIT), Autolus Therapeutics plc (AUTL), Aura Biosciences, Inc. (AURA), Indaptus Therapeutics, Inc. (INDP).